TRIM26 and metabolic dysfunction-associated steatohepatitis: To investigate in depth and identify the major catalytic substrate of TRIM26 in NASH pathology, an RNA-seq assay was next used to analyse gene expression changes in L02 cells with adenovirus-mediated TRIM26 overexpression (AdTRIM26) after a 10 h PAOA challenge (Fig. 2a).